Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary hypertension: NO therapy?

S Adnot1, B Raffestin

  • 1Département de Physiologie et INSERM U296, Hôpital Henri Mondor, Créteil, France.

Thorax
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung mTOR activation leads to lung fibrosis or emphysema via senescence of specific lung cells.

Scientific reports·2026
Same author

[Senescence of the pulmonary endothelial cells: VEGF, a new target in pulmonary pathologies and aging].

Revue des maladies respiratoires·2025
Same author

[Discussion about the presentation: "Cell senescence, a new target for respiratory viral infections: from influenza virus to SARS-CoV-2"].

Bulletin de l'Academie nationale de medecine·2023
Same author

[Cell senescence, a new target for respiratory viral infections: From influenza virus to SARS-CoV-2].

Bulletin de l'Academie nationale de medecine·2023
Same author

Axial stretch-dependent cation entry in dystrophic cardiomyopathy: Involvement of several TRPs channels.

Cell calcium·2016
Same author

[Cellular senescence and pulmonary disease: COPD as an example].

Revue des maladies respiratoires·2014

Nitric oxide (NO) is vital for lung health, regulating blood vessels and preventing hypertension. Impaired NO production worsens pulmonary hypertension, but inhaled NO gas offers a targeted treatment.

Area of Science:

  • Pulmonary Medicine
  • Vascular Biology
  • Cardiovascular Research

Background:

  • Endothelium-derived nitric oxide (NO) is a key pulmonary vasodilator.
  • NO regulates platelet aggregation, smooth muscle growth, and vasoactive substance expression.
  • Reduced NO production is linked to pulmonary hypertension and vascular remodeling.

Purpose of the Study:

  • To highlight the role of nitric oxide in pulmonary vascular health.
  • To discuss the therapeutic potential of exogenous nitric oxide in lung disorders.

Main Methods:

  • Review of existing literature on nitric oxide in pulmonary circulation.
  • Analysis of the mechanisms underlying NO's vasodilatory and anti-proliferative effects.
  • Examination of clinical applications of inhaled nitric oxide therapy.

Related Experiment Videos

Main Results:

  • Endogenous NO plays a critical role in maintaining pulmonary vascular tone and integrity.
  • Deficiency in NO contributes to the pathophysiology of pulmonary hypertension.
  • Exogenous NO gas selectively targets pulmonary vasculature, acting as a potent vasodilator.

Conclusions:

  • Restoring or supplementing NO pathways is a promising strategy for managing pulmonary hypertension.
  • Inhaled nitric oxide is an established treatment for specific lung conditions, demonstrating selective pulmonary vasodilation.